FHIR Release 3 (STU) Current Build
This page is part of FHIR STU 3 (v3.0.1) in it's permanent home (it will always be available at this URL). It has been superceded by R4 . For a full list of available versions, see the Directory of published versions .

Detectedissue-example

Clinical Decision Support Work Group Maturity Level : N/A Ballot Standards Status : Informative Compartments : Device , Patient , Practitioner

This is the narrative for the resource. See also the XML or , JSON or Turtle format. This example conforms to the profile DetectedIssue .


Severity: High - Risk of internal bleeding

Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.

Mitigation: Jan 5, 2014 by Dr. Adam Careful:

Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring


 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.